[AsCNP_P28] ポスター28
Schizophrenia 7

[AsCNP-P28-2] Glutamatergic Neurometabolite Levels in Patients with Severe Treatment-Resistant Schizophrenia: A Cross-Sectional 3T Proton Magnetic Resonance Spectroscopy Study

^○Ryosuke TARUMI^{1, 2}, Sakiko TSUGAWA¹, Yoshihiro NODA¹, Plitman ERIC^{3, 4}, Shiori HONDA⁵, Karin MATSUSHITA⁶, Sofia CHAVEZ ⁷, Kyosuke SAWADA¹, Masataka WADA¹, Mie MATSUI⁸, Shinya FUJII⁶, Takahiro MIYAZAKI¹, Mallar CHAKRAVARTY^{3, 4, 9}, Hiroyuki UCHIDA^{1, 7}, Gary REMINGTON^{7, 10}, Ariel GRAFF-GUERRERO^{7, 10}, Masaru MIMURA¹, Shinichiro NAKAJIMA^{1, 7} (1. Department of Neuropsychiatry Keio University School of Medicine, Tokyo, Japan, 2. Department of Psychiatry, Komagino Hospital, 3. Cerebral Imaging Centre, Douglas Mental Health University Institute, McGill University, Montreal, Canada, 4. Department of Psychiatry, McGill University, Montreal, Canada, 5. Faculty of Environment and Information Studies, Keio University, 6. Faculty of Environment and Information Studies, Keio University, 7. Campbell Institute Research Program, Centre for Addiction and Mental Health, Toronto, Canada, 8. Department of Clinical Cognitive Neuroscience, Institute of Liberal Arts and Science, Kanazawa University, Kanazawa, Japan, 9. Department of Biomedical Engineering, McGill University, Montreal, Canada, 10. Department of Psychiatry, University of Toronto, Toronto, Canada)